Amphotericin B lipid complex

Generic name
Amphotericin B lipid complex
Brand name
ATC Code
J02AA01
Compare …

Amphotericin B lipid complex

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Systemic mycoses
  • Intravenous
    • Term neonate
      • 2.5 - 5 mg/kg/day in 1 dose
    • 1 month up to 18 years
      • 3 - 5.5 mg/kg/day in 1 dose The maximum cumulative dose is 10 g
        (NOTE: THE CALCULATOR DOES NOT CHECK THE CUMULATIVE DOSE!).

      • The manufacturer of Abelcet recommends a test dose of 0.1 mg/kg and a maximum of 1 mg. There is no scientific foundation for this. It also does not give a reliable prediction for the tolerance.

Renal impaiment in children > 3 months

Adjustment in renal impairment as specified:

GFR 50-80 ml/min/1.73 m2
Adjustment not necessary.
GFR 30-50 ml/min/1.73 m2
Adjustment not necessary.
GFR 10-30 ml/min/1.73 m2
Adjustment not necessary.
GFR < 10 ml/min/1.73 m2
No generalized dose recommendations are given

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIMYCOTICS FOR SYSTEMIC USE

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Antibiotics
J02AA01
J02AA01
J02AA01
Triazole and tetrazole derivatives
J02AC01
J02AC05
J02AC02
J02AC04
J02AC03
Other antimycotics for systemic use
J02AX06
J02AX04
J02AX01
J02AX05

References

  1. Hartwig NC, et al, Vademecum pediatrische antimicrobiele therapie, 2005
  2. Cephalon Ltd., SPC Abelcet (RVG 20850) 17-09-2018, www.geneesmiddeleninformatiebank.nl
  3. Pane ZD et al., Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update., Expert Opin Pharmacother, 2015, Apr;16(5), 693-10

Changes

Therapeutic Drug Monitoring


Overdose